The aim of the COVID Symptom Study (CSS) Biobank is to understand the impact and effects of COVID-19 and how these may be linked with health conditions and other genetic and environmental factors.
We want to collect clinical and questionnaire data, and samples such as blood, to understand how the body responds to the coronavirus that causes COVID-19, and how COVID-19 affects the body in the long-term. Combining this data with your regular COVID Symptom Study app logs will give us detailed information about COVID-19.
Participation in the CSS Biobank is currently by invitation only.
The CSS Biobank is led by researchers from King’s College London.